Thursday, September 18, 2025 9/18/2025

Role of cDC2 subsets in host protection and CD4T cell responses in melanoma

Award Number: R21CA259541
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2021
PERIOD OF PERFORMANCE END DATE: 01/31/2024

Group Awards By:

View Award Description

Role of cDC2 subsets in host protection and CD4T cell responses in melanoma - Project Summary Despite recent successes, many melanoma patients still fail to respond to immunotherapy and there is a pressing need for identifying novel therapeutic targets. The primary goal of immunotherapy is to activate tumor- specific immune responses, in which tumor-specific T cells play a crucial role. Although cytotoxic CD8T cells have long been the main focus of research on tumor-specific immunity, growing evidence shows the contribution of CD4T cells to tumor rejection, especially in tumors treated with immunogenic therapy. However, the mechanism of CD4T cell activation in melanoma is less well understood compared to that of CD8T cells. Type 2 conventional dendritic cells (cDC2s) have high antigen presenting capacity to activate antigen-specific CD4T cells, but their role in tumor immunity has not been fully understood due partially to the phenotypic heterogeneity within this cell type. We previously identified CD301b+ DCs as the major cDC2 population in the mouse skin and showed that they transport antigens from the skin to the draining lymph node and efficiently prime antigen-specific CD4T cells. This proposal focuses on understanding their role in host protection and CD4T cell activation in experimental melanoma models in mice. To understand how cDC2 cells respond to the tumor microenvironment at the molecular level, we employ a novel technique of single-cell RNA sequencing to identify subset-specific gene expression changes in cDC2 subsets during melanoma progression. In parallel, we use targeted cell depletion approaches to identify the cellular mechanisms of cDC2-depedent host protection in both untreated melanoma as well as in those treated with immunogenic therapy. These experiments will collectively provide comprehensive understanding on the role of cDC2 subsets in melanoma and potentially reveal new cellular pathways that lead to activation of melanoma-specific CD4T cells.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	RUTGERS, THE STATE UNIVERSITY	185 S ORANGE AVE	NEWARK	NJ	07103	ESSEX	USA	Cancer Treatment Research	000	2	5/29/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $174,406 )
2022	2022	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY	185 S ORANGE AVE	NEWARK	NJ	07103	ESSEX	USA	Cancer Treatment Research	000	2	1/11/2022	NON-COMPETING CONTINUATION	$160,167
2022	2022	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY	185 S ORANGE AVE	NEWARK	NJ	07103	ESSEX	USA	Cancer Treatment Research	001	2	4/29/2022	NON-COMPETING CONTINUATION	$14,239
														Subtotal = $174,406

Issue Date FY: 2021 ( Subtotal = $214,012 )
2021	2021	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY	185 S ORANGE AVE	NEWARK	NJ	07103	ESSEX	USA	Cancer Treatment Research	000	1	1/20/2021	NEW	$214,012
														Subtotal = $214,012

Grand Total All Awards = $388,418

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of cDC2 subsets in host protection and CD4T cell responses in melanoma

Award Number: R21CA259541

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2021

PERIOD OF PERFORMANCE END DATE: 01/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer